"Invizyne is taking what nature has done and [...] putting things in a manufacturing format so we can make materials at low cost and really help the sustainability of this planet." ~ states synthetic biology key opinion leader, Dr. James J. Lalonde, in an interview.

You can see the full interview here:
Invizyne IPO - KOL Call with Dr. James J. Lalonde (July 17, 2024)

#biomanufacturing #nextgenbiomanufacturing #cellfree #enzymes #biochemistry #biochemicals #synbio #syntheticbiology #synbiobeta #biosynthesis #simplepath #scalablebiochemistry #scalable #energytransition #endocannabinoids #cannabinoids #sustainableaviationfuel #SAF #greentech #cleantech